Evidence map›Paper›PMID 39324138›Full record

ArticleFrontiers in immunology2024

Clinical significance of T helper cell subsets in the peripheral blood and bone marrow of patients with multiple myeloma.

Liangjun Zhang, Huixiu Zhong, Jiwen Fan, Jiansen Mao, Yi Li

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liangjun Zhang *Department of Laboratory Medicine, Zigong First People's Hospital, Zigong, China.
Huixiu Zhong *Department of Laboratory Medicine, Zigong First People's Hospital, Zigong, China.
Jiwen FanDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Jiansen MaoDepartment of Laboratory Medicine, Nanjing International School, Nanjing, China.
Yi LiDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: T helper (Th) cell subsets primarily assist B cells in differentiating into plasma cells in the germinal center. The mechanism of malignant transformation of plasma cells is an important target for the clinical treatment of MM; however, the mechanism remains unclear. Methods: We collected the peripheral blood (PB) and bone marrow (BM) samples of 33 patients with MM. In addition, the PB was also collected from 25 normal healthy controls (HCs). We analyzed the percentages of Th cell subsets in the PB and BM samples of patients with MM. Results: Tfh/CD4 Conclusion: Th cell subsets play an important role in the occurrence and development of MM and may provide a fundamental basis for identifying new immunotherapy targets and prognosis.

Indexed as

Bone MarrowMultiple MyelomaT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsAdultAgedAged, 80 and overClinical RelevanceFemaleHumansMaleMiddle AgedPrognosischemotherapymultiple myelomaprognosisT follicular helperT helper cells

Identifiers

PMID39324138
PMCPMC11422089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.